CLDX   $33.86  -0.03% Market Closed After Close 34.0 0.41%

Celldex Therapeutics, Inc.
Last Events:

2023-11-06 The hottest instrument.

2023-08-05 Trend pattern changed from восходящий треугольник to симметричный треугольник.

2023-08-05 Signal in Stochastic changed from bearish weakening to bearish recovery. The stochastic indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: main and signal line crossing.

2023-08-03 Signal in Stochastic changed from bearish recovery to bearish weakening. The stochastic indicator is in the lower part of the neutral territory and it grows. These factors indicate that the upside trend is confirmed. Last signal: main and signal line crossing.

2023-08-03 Signal in MACD changed from bearish reversal to bearish. Oscillator MACD is in the negative territory it's lower than the signal line and it crossed the zero line from the top. These factors mean that there is probably a falling trend. Last signal: down-crossing the middle level.

2023-08-03 Signal in RSI changed from bearish weakening to bearish recovery. RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

2023-08-03 Trend Power changed from almost flat to slow.

2023-08-02 Trend Power changed from slow to almost flat.


Current temperature: 5.08
ST: 0, Cor:

50-50 Year Forecast
Low with % probability:
Target: 29.21
High with % probability:
Analyst Recommendations:
Number of estimates 15
Target Price Mean 54.33
Mean unverified/preliminary 54.33 / 54.33
Target Price Low / High 24.00 / 90.00
Median / STD DEV 48.00 / 18.79
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Buy ActivelyBuy ActivelyBuy
rsi ActivelyBuy ActivelyBuy Buy
macd ActivelyBuy None None
stoch ActivelyBuy None None
ma20 Sell ActivelyBuy Buy
ma50 ActivelyBuy None None
ma100 None ActivelyBuy ActivelyBuy
Candlestick PatternApril 16, 2026 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US15117B2025
ceo Mr. Anthony S. Marucci M.B.A.
Website https://www.celldex.com
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.